Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
Clinic Signification:
1.Abnormal C-MYC breakapart occurs in 5% of B-ALL patients and can be fused with multiple genes. About 75% of mature B-cell patients with acute leaching exhibit FAB ALL-L3 in morphology, often accompanied by typical t(8 ; 14) (q24; q32).
2.Abnormal MYC breakapart means that the prognosis is extremely poor, causing resistance to chemotherapy drugs, which leads to the rapid development of the disease. The clinical manifestation is more invasive.
C-MYC Normal
C-MYC Breakapart
Probe Description: C-MYC
Cat.No.: CF1256
Specification: 10 tests/box, 20 tests/box